Comprehensive Review of Animal Bacterial Diseases: Pathogenesis, Diagnosis, and Management

1. Introduction

Bacterial infections represent a major cause of morbidity, mortality, and economic loss in animal production systems worldwide. The clinical spectrum ranges from acute fulminant septicemia to chronic subclinical infections that impair productivity and welfare [1]. The multifactorial nature of bacterial disease pathogenesis involves complex interactions among host immunity, environmental stressors, microbial virulence factors, and the capacity of bacteria to form biofilms [46, 59]. Accurate diagnosis relies on a combination of conventional culture, serological assays, and molecular techniques such as polymerase chain reaction (PCR) and high-throughput sequencing [74]. The emergence of antimicrobial resistance (AMR) in livestock-associated pathogens has intensified the need for integrated management strategies that reduce antibiotic reliance while maintaining animal health [48, 54].

This review provides a comprehensive examination of bacterial disease pathogenesis, diagnostic methodologies, and management approaches across major animal species. Emphasis is placed on the biophysical and molecular mechanisms underlying host-pathogen interactions, the physics of diagnostic platforms, and evidence-based control measures. The article adheres to a One Health perspective, recognizing the interconnectedness of animal, human, and environmental health [44, 50].

2. Bacterial Pathogenesis in Animals

2.1 Molecular Mechanisms of Virulence

Bacterial virulence is mediated by an array of factors including adhesins, toxins, secretion systems, and biofilm-forming capabilities. Gram-negative pathogens such as Pasteurella multocida and Mannheimia haemolytica produce leukotoxins and lipopolysaccharides that trigger inflammatory cascades in the respiratory tract of cattle and sheep [1]. The type VI secretion system (T6SS) has been characterized in Vibrio parahaemolyticus and other aquatic pathogens, facilitating direct injection of effector proteins into host cells [133]. Extracellular vesicles released by bacteria, including those from Corynebacterium parakroppenstedtii, contain bioactive glycolipids that promote granulomatous inflammation [2].

Biofilm formation is a critical survival strategy that protects bacteria from host immune defenses and antimicrobial agents [46, 67]. Biofilms are structured communities encased in a self-produced extracellular polymeric matrix composed of polysaccharides, extracellular DNA (eDNA), and amyloid fibers [129]. The second messenger cyclic diguanylate monophosphate (c-di-GMP) regulates biofilm formation in Leptospira spp. and many other bacteria, controlling the transition from planktonic to sessile lifestyles [69]. In livestock, biofilm-associated infections have been documented in mastitis, bovine respiratory disease, and chronic wounds [46, 59]. The presence of eDNA and amyloid fibers synergistically stabilizes the matrix and contributes to antimicrobial tolerance [129].

2.2 Pathogenesis of Key Livestock Bacterial Diseases

2.2.1 Bovine Respiratory Disease Complex

Bovine respiratory disease (BRD) is a leading cause of economic loss in feedlot cattle, arising from the interplay of viral priming and secondary bacterial invasion [1]. M. haemolytica, P. multocida, Histophilus somni, and Mycoplasma bovis are the primary bacterial agents [1]. Viral infections (e.g., bovine herpesvirus-1) compromise mucociliary clearance and suppress alveolar macrophage function, enabling bacterial adherence and proliferation [65]. M. haemolytica leukotoxin induces cytolysis of neutrophils and macrophages, releasing proinflammatory cytokines and causing fibrinonecrotic pneumonia [49].

2.2.2 Bovine Mastitis

Mastitis is an inflammation of the mammary gland typically caused by bacterial infection [45, 73]. Major pathogens include Staphylococcus aureus, Streptococcus agalactiae, and Escherichia coli [3]. S. aureus produces a range of toxins and biofilm-forming factors that facilitate intramammary persistence and chronic infection [3]. The host inflammatory response, mediated by interleukin-6 and other cytokines, contributes to tissue damage and reduced milk quality [45, 73]. Subclinical mastitis remains a diagnostic challenge as it lacks overt clinical signs but leads to elevated somatic cell counts [45].

2.2.3 Brucellosis

Brucellosis, caused by Brucella abortus, B. melitensis, and B. suis, is a zoonotic disease affecting cattle, camels, goats, sheep, and wildlife [4, 5]. Brucella species are facultative intracellular pathogens that survive within macrophages by inhibiting phagolysosome fusion and modulating host immune responses [72, 114]. The STING signaling pathway in macrophages plays a critical role in controlling B. abortus infection through type I interferon induction [114]. Brucellosis leads to reproductive losses, including abortion and infertility, with significant economic repercussions in endemic regions [6].

2.2.4 Tuberculosis in Animals

Mycobacterial infections, particularly Mycobacterium bovis, cause tuberculosis in cattle, wildlife, and humans [7]. Transmission occurs via aerosol inhalation or ingestion. The pathogen induces granuloma formation in lungs and lymph nodes, characterized by central caseous necrosis and macrophage aggregation [8]. Mycobacterium avium subspecies paratuberculosis causes Johne's disease, a chronic enteritis of ruminants, and has been controversially linked to Crohn's disease in humans [9]. Reverse zoonosis, where humans transmit M. tuberculosis to cattle, is an emerging concern [122].

2.2.5 Enteric Bacterial Infections

Salmonellosis, colibacillosis, and clostridial enterotoxemias are important enteric diseases of livestock and poultry. Salmonella enterica serovars colonize the intestinal tract and can invade systemic tissues, leading to septicemia and enteritis [90, 127]. Shiga toxin-producing E. coli (STEC) produce Stx1 and Stx2 toxins that damage microvascular endothelial cells, causing hemorrhagic diarrhea and hemolytic uremic syndrome [41, 138]. Clostridium perfringens type D produces epsilon toxin responsible for pulpy kidney disease (enterotoxemia) in sheep and goats, characterized by increased vascular permeability and neurological signs [68, 128].

2.3 Biofilms in Chronic Infections

Bacterial biofilms have been documented across multiple body systems in animals, including the respiratory, urinary, integumentary, and reproductive tracts [46, 67]. In the udder, S. aureus biofilms contribute to persistent subclinical mastitis that resists antibiotic therapy [3]. Biofilms also play a role in otitis, chronic rhinosinusitis, and wound infections [10]. Quorum sensing (cell-to-cell communication) regulates biofilm maturation and virulence gene expression [70]. The extracellular polymeric substance acts as a physical barrier to immune cells and antimicrobials, while persister cells within the biofilm exhibit metabolic dormancy that further complicates eradication [59].

3. Diagnosis of Bacterial Diseases

3.1 Conventional Diagnostic Methods

Traditional diagnosis relies on clinical examination, gross pathology, and microbiological culture. Isolation of bacteria from clinical specimens (milk, nasal swabs, feces, tissues) remains the gold standard for definitive identification [1]. Biochemical profiling and serotyping are used for speciation, as exemplified by the distinction of P. multocida serotypes in avian cholera [11]. The California Mastitis Test and somatic cell counting are indirect indicators of intramammary inflammation [45].

3.2 Serological Assays

Enzyme-linked immunosorbent assays (ELISAs) are widely employed for detecting antibodies against Brucella spp., Mycobacterium bovis, and Leptospira spp. [12]. The milk ring test is used for brucellosis screening in dairy herds [44]. Indirect ELISAs for p27 antigen detection in feline leukemia virus serve as a comparative model for bacterial antigen detection [see Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus]. While serology is useful for herd-level surveillance, sensitivity can be limited in chronic infections where animals become seronegative [12].

3.3 Molecular Detection

Nucleic acid amplification techniques, particularly PCR and quantitative PCR (qPCR), have revolutionized bacterial detection by offering high sensitivity and specificity [12]. Real-time qPCR enables quantification of bacterial loads in clinical samples, which can correlate with disease severity [45]. Multiplex PCR panels allow simultaneous detection of multiple pathogens, such as BRD agents [1] and mastitis pathogens [73]. High-throughput sequencing (metagenomics) provides unbiased identification of entire bacterial communities and has been applied to characterize the lung microbiome in respiratory disease [60].

Loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA) are emerging point-of-care molecular tools that do not require thermal cycling [74]. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) allows rapid identification of bacterial colonies based on protein profiles, replacing traditional biochemical testing in many laboratories [45].

Table 1 summarizes the comparative performance of diagnostic methods.

3.4 Advanced Imaging and Biophysical Techniques

Ultrasonography and thermographic imaging can detect udder inflammation in mastitis [45]. Molecular imaging using radiolabeled tracers targeting bacterial metabolism (e.g., maltodextrin-based probes) is under development for localizing deep-seated infections [13]. Viscoelastic testing (thromboelastography) assesses fibrinolytic dysfunction in sepsis, providing prognostic information [14].

4. Management and Control Strategies

4.1 Antimicrobial Therapy

Antibiotics remain the cornerstone of bacterial disease treatment, but their efficacy is threatened by AMR [3, 15]. The selection of antimicrobials should be guided by culture and antimicrobial susceptibility testing (AST) to ensure appropriate therapy [16]. In bovine foot rot, ceftiofur formulations are effective, but resistance patterns vary regionally [16]. For mastitis, intramammary and systemic antibiotic protocols are employed during lactation and the dry period [52, 73].

4.2 Antimicrobial Resistance

AMR in animal pathogens is driven by selective pressure from antibiotic use, horizontal gene transfer via plasmids and genomic islands, and biofilm-mediated tolerance [15]. Methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL)-producing E. coli are of particular concern [17, 3]. Carbapenem-resistant Acinetobacter baumannii has emerged in veterinary settings [82]. Comprehensive surveillance and antimicrobial stewardship programs are critical to mitigate AMR [44, 58].

4.3 Vaccination

Vaccines are essential tools for preventing bacterial diseases and reducing antibiotic use [48, 64]. Live attenuated vaccines are available for brucellosis (e.g., B. abortus S19, B. melitensis Rev.1), though they interfere with serological surveillance [64]. Autogenous vaccines are used for herd-specific mastitis pathogens. Recombinant subunit vaccines and outer membrane vesicle-based vaccines represent next-generation platforms [111]. Multi-epitope vaccines targeting tick-borne bacteria are under development [99].

4.4 Biosecurity and Herd Management

Preventive measures include all-in/all-out production systems, quarantine of new arrivals, hygiene protocols, and environmental management [1]. For BRD, reducing transport stress and ensuring adequate colostrum intake are protective [1]. In mastitis control, pre- and post-milking teat disinfection, dry cow therapy, and culling of chronically infected cows reduce incidence [45, 73]. Biosecurity is also crucial for preventing zoonotic transmission of brucellosis, tuberculosis, and leptospirosis [43, 50].

4.5 Alternative and Adjunctive Therapies

Given rising AMR, alternative strategies have been explored. Bacteriophage therapy and endolysins show promise against S. aureus and E. coli infections [97, 117, 116]. Antimicrobial peptides (AMPs) can synergize with conventional antibiotics to delay resistance emergence [104, 134]. Probiotics and prebiotics modulate the gut microbiota to inhibit pathogen colonization [18]. Nanoparticle-based drug delivery systems improve antibiotic targeting [52]. Fibrinolysis-modulating agents may improve outcomes in sepsis [14].

4.6 Integrated Disease Management

A systems-based approach combining diagnostics, vaccination, biosecurity, and prudent antimicrobial use is essential for sustainable control [1]. The decision-making process for managing a suspected bacterial outbreak is illustrated in the Mermaid diagram below.

graph TD
    A[Clinical Signs Observed] --> B[Sample Collection]
    B --> C[Laboratory Diagnostics]
    C --> D{Culture & AST}
    C --> E[Molecular Detection]
    C --> F[Serology]
    D & E & F --> G[Pathogen Identification & Resistance Profile]
    G --> H[Select Targeted Antimicrobial]
    G --> I[Implement Biosecurity]
    H --> J[Treat Affected Animals]
    I --> K[Prevent Spread to Naive Animals]
    J & K --> L[Monitor Treatment Response]
    L --> M{Clinical Improvement?}
    M -- Yes --> N[Continue Management & Surveillance]
    M -- No --> O[Re-evaluate Diagnosis & AST]
    O --> G

5. One Health Implications

Many bacterial diseases of animals are zoonotic. Brucellosis, tuberculosis, leptospirosis, salmonellosis, and anthrax pose direct risks to humans through occupational exposure or consumption of contaminated animal products [4, 19]. The One Health approach integrates veterinary, medical, and environmental surveillance to detect and control these pathogens at the human-animal-environment interface [44, 56, 88]. For example, Coxiella burnetii (Q fever) circulates among livestock, ticks, and humans, requiring coordinated control efforts [75, 88]. Wildlife reservoirs, such as deer and wild boar, can sustain pathogens like Mycobacterium bovis and Brucella spp., complicating eradication [7].

6. Emerging and Re-emerging Bacterial Pathogens

Novel bacterial species continue to be identified due to improved molecular diagnostics. Escherichia albertii has emerged as a foodborne pathogen with zoonotic potential [137]. Serratia marcescens is an opportunistic pathogen in aquaculture and hospital settings [136]. Tenacibaculum maritimum causes tenacibaculosis in marine fish [20]. The expansion of tick vectors due to climate change is facilitating the spread of Borrelia spp., Anaplasma spp., and Ehrlichia spp. into new geographic regions [21, 22]. Surveillance using metagenomic approaches is essential for early detection of these threats [60].

7. Conclusion

Animal bacterial diseases remain a formidable challenge to livestock productivity, animal welfare, and public health. Understanding the molecular mechanisms of pathogenesis, including biofilm formation and virulence factor regulation, is fundamental to developing effective interventions. Advances in molecular diagnostics, from qPCR to metagenomics, have improved the speed and accuracy of pathogen identification. However, the escalating crisis of antimicrobial resistance demands a paradigm shift toward integrated management strategies that prioritize vaccination, biosecurity, and alternative therapies. Cross-sectoral collaboration under the One Health framework is imperative to mitigate the impact of these diseases and safeguard global health.

References

[1] Storoni C, Preziuso S, Attili AR, et al. Bacterial Bovine Respiratory Disease: A Comprehensive Review of Etiology, Pathogenesis and Management Strategies. Microbiology Research. 2026. https://www.semanticscholar.org/paper/ab927dab3f5f7ffbc8ef2e1996d5f38feec429ee

[2] Liu R, Luo Z, Dai C, et al. Corynebacterium parakroppenstedtii secretes a novel glycolipid to promote the development of granulomatous lobular mastitis. Signal Transduct Target Ther. 2024. https://pubmed.ncbi.nlm.nih.gov/39428541/

[3] Getahun DD, Tarekegn HT, Azene BT, et al. Virulence genes and antibiotic resistance profiling of staphylococcus species isolated from mastitic dairy cows in and around Bahir dar, Ethiopia. BMC Microbiol. 2025. https://pubmed.ncbi.nlm.nih.gov/40221685/

[4] Dadar M, Foster JT. Camel brucellosis: a narrative review of epidemiology and control strategies. Vet Res Commun. 2025. https://pubmed.ncbi.nlm.nih.gov/41324816/

[5] Qureshi KA, Parvez A, Fahmy NA, et al. Brucellosis: epidemiology, pathogenesis, diagnosis and treatment-a comprehensive review. Ann Med. 2023. https://pubmed.ncbi.nlm.nih.gov/38165919/

[6] Abdel-Rady A, Abu-Seida HA, Abu-Seida AM. An Overview of Camel Brucellosis and Its Impact on Human Health in Endemic Regions. Vector Borne Zoonotic Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/40966120/

[7] Ramanujam H, Palaniyandi K. Tuberculosis in wild animals in India. Vet Res Commun. 2024. https://pubmed.ncbi.nlm.nih.gov/38771446/

[8] Kim PM, Lee JJ, Choi D, et al. Endothelial lineage-specific interaction of Mycobacterium tuberculosis with the blood and lymphatic systems. Tuberculosis (Edinb). 2018. https://pubmed.ncbi.nlm.nih.gov/30029892/

[9] Naser SA, Sagramsingh SR, Naser AS, et al. Mycobacterium avium subspecies paratuberculosis causes Crohn's disease in some inflammatory bowel disease patients. World J Gastroenterol. 2014. https://pubmed.ncbi.nlm.nih.gov/24966610/

[10] Scalise A, Bianchi A, Tartaglione C, et al. Microenvironment and microbiology of skin wounds: the role of bacterial biofilms and related factors. Semin Vasc Surg. 2015. https://pubmed.ncbi.nlm.nih.gov/27113281/

[11] Christensen JP, Bisgaard M. Fowl cholera. Rev Sci Tech. 2000. https://pubmed.ncbi.nlm.nih.gov/10935284/

[12] Islam MS, Habib MA, Tonu NS, et al. Beyond Serology: A Meta-Analysis of Advancements in Molecular Detection of Brucella spp. in Seronegative Animals and Biological Samples. Vet Med Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/39792571/

[13] Bunschoten A, Welling MM, Termaat MF, et al. Development and prospects of dedicated tracers for the molecular imaging of bacterial infections. Bioconjug Chem. 2013. https://pubmed.ncbi.nlm.nih.gov/24200346/

[14] Scarlatescu F, Scărlătescu E, Thachil J, et al

[15] Murphy CP, Carson C, Smith BA, et al. Factors potentially linked with the occurrence of antimicrobial resistance in selected bacteria from cattle, chickens and pigs: A scoping review of publications for use in modelling of antimicrobial resistance (IAM.AMR Project). Zoonoses Public Health. 2018. https://pubmed.ncbi.nlm.nih.gov/30187682/

[16] Kausche FM, Robb EJ. A comprehensive review of ceftiofur sodium and hydrochloride formulations for treatment of acute bovine foot rot. Vet Ther. 2003. https://pubmed.ncbi.nlm.nih.gov/12756639/

[17] Kiongo NK, Maingi JM, Nyongesa KW, et al. Extended-spectrum β-lactamase and carbapenemase-producing bacteria urinary tract infections in adult HIV-positive outpatients at Embu County Referral Hospital, Kenya. BMC Microbiol. 2025. https://pubmed.ncbi.nlm.nih.gov/41239217/

[18] Abd El-Hack ME, El-Saadony MT, Elbestawy AR, et al. Necrotic enteritis in broiler chickens: disease characteristics and prevention using organic antibiotic alternatives - a comprehensive review. Poult Sci. 2022. https://pubmed.ncbi.nlm.nih.gov/34953377/

[19] Dhama K, Karthik K, Tiwari R, et al. Listeriosis in animals, its public health significance (food-borne zoonosis) and advances in diagnosis and control: a comprehensive review. Vet Q. 2015. https://pubmed.ncbi.nlm.nih.gov/26073265/

[20] Mabrok M, Algammal AM, Sivaramasamy E, et al. Tenacibaculosis caused by Tenacibaculum maritimum: Updated knowledge of this marine bacterial fish pathogen. Front Cell Infect Microbiol. 2022. https://pubmed.ncbi.nlm.nih.gov/36683696/

[21] Korenberg EI. Problems in the study and prophylaxis of mixed infections transmitted by ixodid ticks. Int J Med Microbiol. 2004. https://pubmed.ncbi.nlm.nih.gov/15146988/

[22] Moustafa MAM, Schlachter S, Parveen N. Innovative Strategies to Study the Pathogenesis of Elusive Spirochetes and Difficulties Managing the Chronic Infections They Cause. Annu Rev Microbiol. 2024. https://pubmed.ncbi.nlm.nih.gov/39107040/

[23] Tulu B, Brehm TT, van Crevel R, et al. Host- and pathogen-related determinants of pulmonary versus extrapulmonary tuberculosis. Eur Respir Rev. 2026. https://pubmed.ncbi.nlm.nih.gov/41605541/

[24] GBD 2023 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Infect Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/41412141/

[25] Shi L, Wang B, Peng D, et al. Brucella-associated hemophagocytic syndrome: case report of a potentially life-threatening condition and literature review. Front Immunol. 2025. https://pubmed.ncbi.nlm.nih.gov/40787452/

[26] Inglis C, Wen SCH, Kapoor V. Infantile Pasteurella multocida Meningitis: Case Report and Review of the Literature. Pediatr Infect Dis J. 2025. https://pubmed.ncbi.nlm.nih.gov/40063964/

[27] Zeng ZY, Ding ZL, Zhou AN, et al. Bacterial diseases in Siniperca chuatsi: status and therapeutic strategies. Vet Res Commun. 2024. https://pubmed.ncbi.nlm.nih.gov/39373785/

[28] Kant R, Kumar N, Malik YS, et al. Critical insights from recent outbreaks of Mycoplasma pneumoniae: decoding the challenges and effective interventions strategies. Int J Infect Dis. 2024. https://pubmed.ncbi.nlm.nih.gov/39117175/

[29] Kwok CT, Yu RC, Hau PT, et al. Characteristics and pathogenicity of Vibrio alginolyticus SWS causing high mortality in mud crab (Scylla serrata) aquaculture in Hong Kong. Front Cell Infect Microbiol. 2024. https://pubmed.ncbi.nlm.nih.gov/39108984/

[30] Qian B, Ishikawa K, Nakamura T, et al. A Rare Cause of Empyema and Bacteremia Due to Shewanella Species in Alcoholic Cirrhosis Patients: A Case Report and Comprehensive Review of Literature. Am J Case Rep. 2024. https://pubmed.ncbi.nlm.nih.gov/38594894/

[31] Pai KK, Omiunu AO, Peddu DK, et al. Tuberculosis of the middle ear: A systematic review. Am J Otolaryngol. 2022. https://pubmed.ncbi.nlm.nih.gov/35963106/

[32] Reyes S, Nicolau DP. Precision medicine for the diagnosis and treatment of carbapenem-resistant Enterobacterales: time to think from a different perspective. Expert Rev Anti Infect Ther. 2020. https://pubmed.ncbi.nlm.nih.gov/32368940/

[33] Hurtado RM, Meressa D, Goldfeld AE. Treatment of drug-resistant tuberculosis among people living with HIV. Curr Opin HIV AIDS. 2018. https://pubmed.ncbi.nlm.nih.gov/30286039/

[34] Hashish E, Merwad A, Elgaml S, et al. Mycobacterium marinum infection in fish and man: epidemiology, pathophysiology and management; a review. Vet Q. 2018. https://pubmed.ncbi.nlm.nih.gov/29493404/

[35] Vouga M, Greub G. Emerging bacterial pathogens: the past and beyond. Clin Microbiol Infect. 2016. https://pubmed.ncbi.nlm.nih.gov/26493844/

[36] Berger T, Kassirer M, Aran AA. Injectional anthrax - new presentation of an old disease. Euro Surveill. 2014. https://pubmed.ncbi.nlm.nih.gov/25139073/

[37] Sachdeva A, Rawat S, Nagpal J. Efficacy of fermented milk and whey proteins in Helicobacter pylori eradication: a review. World J Gastroenterol. 2014. https://pubmed.ncbi.nlm.nih.gov/24574746/

[38] Bhate C, Schwartz RA. Lyme disease: Part I. Advances and perspectives. J Am Acad Dermatol. 2011. https://pubmed.ncbi.nlm.nih.gov/21414493/

[39] Hookman P, Barkin JS. Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol. 2009. https://pubmed.ncbi.nlm.nih.gov/19340899/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic management.